Affle (India) Limited vs Syngene International Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Affle (India) Limited (Advertising technology) and Syngene International Limited (Contract research, development and manufacturing services for life sciences) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Syngene International Limited leads on Revenue (approx.) and Net profit (approx.).
Syngene International Limited leads on Revenue (approx.) and Net profit (approx.).
Head-to-head highlights
| Metric | Affle (India) Limited | Syngene International Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | Approximately ₹1,800-1,900 crore | Around INR 3,400-3,600 crore, unverified approximate range | AI estimate |
| Net profit (approx.) | Approximately ₹280-320 crore | Around INR 500-600 crore, unverified approximate range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Affle (India) Limited
Advertising technology · India
Affle (India) Limited is an Indian advertising technology company focused on mobile marketing, user acquisition, and consumer intelligence. Its platforms help advertisers acquire, engage, and monetize users across mobile apps and digital channels, with a strong focus on India and other emerging markets.
Verified financials
No source-verified financials available.
Strengths
- Strong mobile-first adtech specialization
- Performance-based advertising model aligned with advertiser ROI
- Presence across India, Southeast Asia, and other growth markets
- Portfolio expanded through acquisitions such as Jampp, mediasmart, and RevX
Weaknesses
- Smaller scale than global platform giants
- Dependence on mobile advertising budgets
- Business complexity from multiple acquired platforms
- Exposure to margin pressure in competitive performance marketing
Opportunities
- Growth in mobile app ecosystems across emerging markets
- Rising advertiser demand for measurable performance marketing
- Expansion of AI-driven campaign optimization and consumer intelligence
- Cross-selling across acquired adtech platforms
Threats
- Privacy regulation and mobile identifier restrictions
- Competition from large walled-garden platforms
- Ad fraud and brand-safety concerns in digital advertising
- Macroeconomic slowdowns affecting advertising spend
Syngene International Limited
Contract research, development and manufacturing services for life sciences · India
Syngene International Limited is an India-based contract research, development and manufacturing organization serving pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical companies. It provides integrated services from early discovery through development and commercial manufacturing, with capabilities across small molecules, biologics and related scientific services.
Verified financials
No source-verified financials available.
Strengths
- Integrated discovery-to-manufacturing service offering
- Established presence in India with access to skilled scientific talent
- Long operating history and credibility with global life-sciences customers
- Capabilities across both small molecules and biologics
Weaknesses
- Customer concentration can affect revenue visibility
- Exposure to regulatory and quality-compliance scrutiny
- Lower scale than leading global CRO/CDMO competitors
- Capital-intensive expansion requirements in manufacturing
Opportunities
- Global pharma outsourcing of R&D and manufacturing
- China-plus-one sourcing strategies benefiting Indian providers
- Growth in biologics and complex modalities
- Expansion into later-stage and commercial manufacturing services
Threats
- Intense competition from global and Indian CRDMO providers
- Regulatory inspection findings or quality issues
- Pricing pressure from large pharmaceutical clients
- Geopolitical, currency and supply-chain volatility
Frequently asked
Answered from source-verified figures on this page.
Affle (India) Limited vs Syngene International Limited: which company leads overall?
Syngene International Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Pharmaceutical Sector — Intelligence Report
Global GLP-1 Obesity Drugs, Oral Incretins and Metabolic Health Services Market — Intelligence Report
Global Digital Health & Telemedicine Market — Intelligence Report
Global Precision Medicine & Genomics Market — Intelligence Report
AI Analyst
Insights and answers generated live from Affle (India) Limited vs Syngene International Limited's verified data. Modeled estimates — not investment advice.
Not enough data yet to generate insights.